Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katherine D Lynch

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Chemosphere|November 4, 2020
Sub-chronic microcystin-LR renal toxicity in rats fed a high fat/high cholesterol dietTarana Arman, Katherine D Lynch, Michael Goedken, et al.
Toxins|July 21, 2019
Sub-Chronic Microcystin-LR Liver Toxicity in Preexisting Diet-Induced Nonalcoholic Steatohepatitis in RatsTarana Arman, Katherine D Lynch, Michelle L Montonye, et al.
Toxicology|November 6, 2021
MCLR-elicited hepatic fibrosis and carcinogenic gene expression changes persist in rats with diet-induced nonalcoholic steatohepatitis through a 4-week recovery periodTarana Arman, J Allen Baron, Katherine D Lynch, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 18, 2019
A Pharmacokinetic Natural Product-Disease-Drug Interaction: A Double Hit of Silymarin and Nonalcoholic Steatohepatitis on Hepatic Transporters in a Rat ModelMichelle L Montonye, Dan-Dan Tian, Tarana Arman, et al.
International Journal of Molecular Sciences|July 14, 2023
Involvement of the p38/MK2 Pathway in MCLR Hepatotoxicity Revealed through MAPK Pharmacological Inhibition and Phosphoproteomics in HepaRG CellsKatherine D Lynch, Dayne T Iverson, Namrata K Bachhav, et al.
Toxicon : Official Journal of the International Society on Toxinology|August 18, 2024
Microcystin-LR activates serine/threonine kinases and alters the phosphoproteome in human HepaRG cellsVictor O Ikumawoyi, Katherine D Lynch, Dayne T Iverson, et al.
Pharmaceutical Research|February 1, 2024
Green Tea Catechins Decrease Solubility of Raloxifene In Vitro and Its Systemic Exposure in MiceVictoria O Oyanna, Baron J Bechtold, Katherine D Lynch, et al.
Molecular Pharmaceutics|March 26, 2024
Rifampin- and Silymarin-Mediated Pharmacokinetic Interactions of Exogenous and Endogenous Substrates in a Transgenic OATP1B Mouse ModelBaron J Bechtold, Katherine D Lynch, Victoria O Oyanna, et al.
Toxicon : Official Journal of the International Society on Toxinology|March 9, 2019
Nonalcoholic fatty liver disease alters microcystin-LR toxicokinetics and acute toxicityJohn D Clarke, Anika Dzierlenga, Tarana Arman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 14, 2024
Pharmacokinetic Effects of Different Models of Nonalcoholic Fatty Liver Disease in Transgenic Humanized OATP1B MiceBaron J Bechtold, Katherine D Lynch, Victoria O Oyanna, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Chemosphere|November 4, 2020
Sub-chronic microcystin-LR renal toxicity in rats fed a high fat/high cholesterol dietTarana Arman, Katherine D Lynch, Michael Goedken, et al.
Toxins|July 21, 2019
Sub-Chronic Microcystin-LR Liver Toxicity in Preexisting Diet-Induced Nonalcoholic Steatohepatitis in RatsTarana Arman, Katherine D Lynch, Michelle L Montonye, et al.
Toxicology|November 6, 2021
MCLR-elicited hepatic fibrosis and carcinogenic gene expression changes persist in rats with diet-induced nonalcoholic steatohepatitis through a 4-week recovery periodTarana Arman, J Allen Baron, Katherine D Lynch, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 18, 2019
A Pharmacokinetic Natural Product-Disease-Drug Interaction: A Double Hit of Silymarin and Nonalcoholic Steatohepatitis on Hepatic Transporters in a Rat ModelMichelle L Montonye, Dan-Dan Tian, Tarana Arman, et al.
International Journal of Molecular Sciences|July 14, 2023
Involvement of the p38/MK2 Pathway in MCLR Hepatotoxicity Revealed through MAPK Pharmacological Inhibition and Phosphoproteomics in HepaRG CellsKatherine D Lynch, Dayne T Iverson, Namrata K Bachhav, et al.
Toxicon : Official Journal of the International Society on Toxinology|August 18, 2024
Microcystin-LR activates serine/threonine kinases and alters the phosphoproteome in human HepaRG cellsVictor O Ikumawoyi, Katherine D Lynch, Dayne T Iverson, et al.
Pharmaceutical Research|February 1, 2024
Green Tea Catechins Decrease Solubility of Raloxifene In Vitro and Its Systemic Exposure in MiceVictoria O Oyanna, Baron J Bechtold, Katherine D Lynch, et al.
Molecular Pharmaceutics|March 26, 2024
Rifampin- and Silymarin-Mediated Pharmacokinetic Interactions of Exogenous and Endogenous Substrates in a Transgenic OATP1B Mouse ModelBaron J Bechtold, Katherine D Lynch, Victoria O Oyanna, et al.
Toxicon : Official Journal of the International Society on Toxinology|March 9, 2019
Nonalcoholic fatty liver disease alters microcystin-LR toxicokinetics and acute toxicityJohn D Clarke, Anika Dzierlenga, Tarana Arman, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 14, 2024
Pharmacokinetic Effects of Different Models of Nonalcoholic Fatty Liver Disease in Transgenic Humanized OATP1B MiceBaron J Bechtold, Katherine D Lynch, Victoria O Oyanna, et al.
Pageof 2